When we examined the association of FOXM1 protein expression to clinicopathological features of patients belonging to the three subtype - specific cohorts, we found that FOXM1 level was significantly higher in serous than clear-cell and endometrioid EOCs, and correlated to advanced FIGO stage, regardless of tumor histotype. The gene discussed is FOXM1; the disease is neoplasm.